These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 19051424)

  • 81. Evolution of knowledge related to breast cancer heterogeneity: a 25-year retrospective.
    Fisher B; Redmond CK; Fisher ER
    J Clin Oncol; 2008 May; 26(13):2068-71. PubMed ID: 18445835
    [No Abstract]   [Full Text] [Related]  

  • 82. [Therapeutic indications in breast cancer].
    Lacour J; Michel G
    Maroc Med; 1972 Nov; 52(562):637-45. PubMed ID: 4352816
    [No Abstract]   [Full Text] [Related]  

  • 83. Ductal carcinoma in situ of the breast with close or focally involved margins following breast-conserving surgery: treatment with reexcision or radiotherapy with increased dosage.
    Monteau A; Sigal-Zafrani B; Kirova YM; Fourchotte V; Bollet MA; Vincent-Salomon A; Asselain B; Salmon RJ; Fourquet A
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1021-8. PubMed ID: 19386441
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Clinical practice guidelines for the care and treatment of breast cancer: the management of ductal carcinoma in situ (summary of the 2001 update).
    Olivotto I; Levine M;
    CMAJ; 2001 Oct; 165(7):912-3. PubMed ID: 11599333
    [No Abstract]   [Full Text] [Related]  

  • 85. Is raloxifene ready to be used for prevention of breast cancer?
    Powles TJ
    Int J Fertil Womens Med; 2006; 51(5):203-4. PubMed ID: 17269585
    [No Abstract]   [Full Text] [Related]  

  • 86. No standard is set for older women with breast cancer.
    Audisio RA; Wyld L
    Eur J Surg Oncol; 2015 May; 41(5):607-9. PubMed ID: 25725950
    [No Abstract]   [Full Text] [Related]  

  • 87. Pure tubular breast carcinoma: a 34 year study of outcomes.
    Wagner TD; Wharton K; Donohue K; Sperl ML; Flaherty L; Jaggernauth W; Yap JC; Fernando SA; Landry JC; Yang GY
    Breast J; 2008; 14(5):512-3. PubMed ID: 18821938
    [No Abstract]   [Full Text] [Related]  

  • 88. Magnetic resonance imaging in the breast cancer patient: curb your enthusiasm.
    Morrow M
    J Clin Oncol; 2008 Jan; 26(3):352-3. PubMed ID: 18202408
    [No Abstract]   [Full Text] [Related]  

  • 89. Ductal carcinoma in situ of the breast; diagnostic assessment and treatment.
    Rutgers EJ; Peterse JL; Bijker N
    Scand J Surg; 2002; 91(3):268-72. PubMed ID: 12449470
    [No Abstract]   [Full Text] [Related]  

  • 90. Thrombotic vasculopathy in a patient with initially undetected breast cancer.
    Emily BJ; Jonida C; Rachita B; Muhammad A; Thomas H
    J Clin Rheumatol; 2014 Sep; 20(6):343-6. PubMed ID: 25160026
    [No Abstract]   [Full Text] [Related]  

  • 91. Breast cancer stage. A number that helps in planning treatment.
    Mayo Clin Womens Healthsource; 2008 Oct; 12(10):1-2. PubMed ID: 18772833
    [No Abstract]   [Full Text] [Related]  

  • 92. [Guideline 'Treatment of breast cancer 2008' (revision)].
    Struikmans H; Nortier JW; Rutgers EJ; Zonderland HM; Bontenbal M; Elkhuizen PH; van Tienhoven G; Tjan-Heijnen VC; van Vegchel T; Tuut MK; Benraadt J
    Ned Tijdschr Geneeskd; 2008 Nov; 152(46):2507-11. PubMed ID: 19055257
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Life after breast cancer.
    Stuart K; Brennan M; French J; Houssami N; Boyages J
    Aust Fam Physician; 2006 Apr; 35(4):219-24. PubMed ID: 16642238
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The Consensus Conference on the treatment of in situ ductal carcinoma of the breast, April 22-25, 1999.
    Schwartz GF; Solin LJ; Olivotto IA; Ernster VL; Pressman PI
    Hum Pathol; 2000 Feb; 31(2):131-9. PubMed ID: 10685626
    [No Abstract]   [Full Text] [Related]  

  • 95. Patient age and positive margins are predictive factors of residual tumor on mastectomy specimen after conservative treatment for breast cancer.
    Voguet L; Hébert T; Levêque J; Acker O; Mesbah H; Marret H; Porée P; Body G
    Breast; 2009 Aug; 18(4):233-7. PubMed ID: 19628389
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Controversies Regarding the Diagnosis and Management of Ductal Carcinoma In Situ.
    Levinsohn E; Altman M; Chagpar AB
    Am Surg; 2018 Jan; 84(1):1-6. PubMed ID: 29428007
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Updates in the Evaluation and Management of Breast Cancer.
    O'Sullivan CC; Loprinzi CL; Haddad TC
    Mayo Clin Proc; 2018 Jun; 93(6):794-807. PubMed ID: 29866283
    [TBL] [Abstract][Full Text] [Related]  

  • 98. The management of ductal and lobular breast cancer.
    Styblo TM; Wood WC
    Surg Oncol; 1999 Aug; 8(2):67-75. PubMed ID: 10732958
    [No Abstract]   [Full Text] [Related]  

  • 99. [Therapeutic indications in breast cancer excluding osseous and visceral metastases].
    Redon H; Verhaeghe M
    J Chir (Paris); 1968; 96(1):79-90. PubMed ID: 4302979
    [No Abstract]   [Full Text] [Related]  

  • 100. [Guidelines for treatment of breast carcinoma by the Gynecological Oncology Working Group. Gynecological Oncology Working Group].
    Concin H; Grünberger W; Kubista E; Menzel C; Pickel H; Reiner A; Seitz W; Sevelda P; Staudach A; Widschwendter M; Wolf G
    Gynakol Geburtshilfliche Rundsch; 1999; 39(4):226-9. PubMed ID: 10629389
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.